168 results on '"Kluk, Michael J."'
Search Results
2. Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation
3. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas
4. NPM1 Biology in Myeloid Neoplasia
5. Spatial Mapping of Human Hematopoiesis at Single Cell Resolution Reveals Aging-Associated Topographic Remodeling
6. Evaluation of S1PR1, pSTAT3, S1PR2, and FOXP1 expression in aggressive, mature B cell lymphomas
7. Detection of Hybrid Fusion Transcripts, Aberrant Transcript Expression, and Specific Single Nucleotide Variants in Acute Leukemia and Myeloid Disorders with Recurrent Gene Rearrangements
8. Lysophospholipids: Receptor Revelations
9. Detection of Hybrid Fusion Transcripts, Aberrant Transcript Expression, and Specific Single Nucleotide Variants in Acute Leukemia and Myeloid Disorders with Recurrent Gene Rearrangements.
10. SINGLE CELL RESOLUTION SPATIAL MAPPING OF HUMAN HEMATOPOIESIS REVEALS AGING-ASSOCIATED TOPOGRAPHIC REMODELING
11. Molecular profiling of the stroke-induced alterations in the cerebral microvasculature reveals promising therapeutic candidates
12. Acute hemolytic anemia after hematopoietic stem cell transplantation: An unusual invader
13. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Lymphoid Neoplasms
14. Chronic Myelogenous Leukemia
15. A novel SF3B1 variant in a patient with MDS with ring sideroblasts
16. Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation
17. Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration
18. Polycomb repressive complex 2 is required for MLL-AF9 leukemia
19. Routine molecular testing of resected early-stage lung adenocarcinoma with targeted next-generation sequencing demonstrates a high rate of actionable mutations
20. MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice
21. Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML
22. Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
23. TCR-dependent transformation of mature memory phenotype T cells in mice
24. Carcinoma and multiple lymphomas in one patient: establishing the diagnoses and analyzing risk factors
25. Lysophospholipids--receptor revelations. (Viewpoint)
26. Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease
27. Clinical Laboratory Validation and Implementation of Quantitative, Real-Time PCR-based Monitoring of NPM1 Type A Mutation
28. Expedited Analysis and Reporting of Multiple Mutations that Modify Medical Management of Myeloid Malignancies
29. Evaluation of S1PR1/pSTAT3 and S1PR2/FOXP1 Expression in Aggressive, Mature B Cell Lymphomas
30. Clinical Laboratory Validation and Implementation of Quantitative, Real-Time PCR-based Detection of NPM1 Type A Mutation.
31. Endothelial sphingosine-1-phosphate receptor 1 deficiency exacerbates brain injury and blood brain barrier dysfunction upon subarachnoid hemorrhage in mice
32. A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas
33. Notch-Regulated Enhancers in B-Cell Lymphoma Activate MYC and Potentiate B-Cell Receptor Signaling
34. Molecular Pathology
35. Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies
36. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
37. Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assay
38. Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke
39. Molecular Classification of MYC-Driven B-Cell Lymphomas by Targeted Gene Expression Profiling of Fixed Biopsy Specimens
40. Cyclin C is a haploinsufficient tumour suppressor
41. NOTCH1 Mutations Occur Early during Cutaneous Squamous Cell Carcinogenesis
42. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
43. Prohibiting employment discrimination on the basis of disability: the need to expand California law.
44. Clinical Characteristics and Treatment Outcome Of CNS Involvement (Bing-Neel Syndrome) In Waldenstrom’s Macroglobulinemia
45. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry
46. Abstract B39: MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma
47. Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms
48. Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
49. Genomic alterations in myeloid neoplasms with novel, apparently balanced translocations
50. Melanoma on the Move: The Progression of Melanoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.